{
  "docId": "019de074-9877-77dd-82aa-a6193fccfe14",
  "docSlug": "e80df986800b3733a06ca071d74e55c6",
  "documentTitle": "OmniAb | Results Presentation Deck | 22 slides",
  "authorId": "omniab",
  "authorName": "OmniAb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 22,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-9877-77dd-82aa-a6193fccfe14/10",
  "deckHref": "/decks/019de074-9877-77dd-82aa-a6193fccfe14",
  "deckJsonHref": "/decks/019de074-9877-77dd-82aa-a6193fccfe14.json",
  "deckAnchorHref": "/decks/019de074-9877-77dd-82aa-a6193fccfe14#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.8,
        "x": 0.18,
        "y": 0.28
      },
      "kind": "image",
      "text": "Partner logos: Janssen, Hanall, Harbour, Immunovant, Gloria, Arcus, Gilead, CStone, EQRx, Pfizer",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bcb7d86f-902c-40d6-a6c3-5b3b6c504ae7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.96,
        "x": 0.02,
        "y": 0.38
      },
      "kind": "list",
      "text": "TECVALI: US Marketing authorization, US launch, $35M milestone payment. Batoclimab: Phase 3 results, Phase 3/2b initiation. Zimberelimab: ARC-7 Phase 2 results. Sugemalimab: UK/EMA marketing authorization acceptance, NMPA supplementary NDA acceptance.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74cfa3d2-f16e-4490-afab-bfbfa4da6656",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.04,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Reference: Partner and Company disclosures",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b772691-81e1-4f35-a93b-e27ef8e98f81",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.85,
        "x": 0.04,
        "y": 0.12
      },
      "kind": "title",
      "text": "SELECT RECENT DEVELOPMENTS SHOW CONTINUED PARTNER MOMENTUM AND PLATFORM VALUE",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "03b63a39-3717-4e8d-9f19-749a125a31aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.35,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Q4 and Recent Updates",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6bf394f4-31fe-4921-9c73-ccfddbed0caa",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 12,
      "from": 10,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "81bc406e-6776-487a-9d98-5632063d35cc",
      "evidence": "SELECT RECENT DEVELOPMENTS SHOW CONTINUED PARTNER MOMENTUM AND PLATFORM VALUE, We Plan to Continue to Innovate Around our Technology",
      "position": 0,
      "objective": "Highlighting the value of continued innovation and partner momentum",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}